The approval would open "up the opportunity for many more people to benefit from tirzepatide," Eli Lilly CEO David Ricks said Thursday on CNBC's "Squawk Box." He added that the drug sets a "new bar for weight loss and people with diabetes." The data come as companies try to capitalize on increased consumer demand for weight loss treatments
Allodynia is a specific type of nerve-related pain where a stimulus that should not be painfullike a light touch, the brush of a shirt, or even a breezecauses discomfort or a burning sensation
While tirzepatide is designed to help regulate blood sugar, it is not known how safe it is for use in pregnant women
Diabetologia 59:13671371 Lao J, Hansen BC, Dimarchi R, Pocai A (2013) Effect of GLP1R/GCGR dual agonist in monkeys
Body-weight fluctuations and outcomes in coronary disease
Our 'one hour vacation' experience is designed for busy professionals and wellness enthusiasts who want effective solutions without sacrificing comfort or time